Loading
This page follows insider dealings at Moss Genomics Inc. as filed with SEDI. Nothing new has been filed by managers of Moss Genomics Inc. in twelve months, the latest record being from 17 July 2025.
The full history, which starts in 2023, counts 3 purchases against 1 sale.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
12 of 12 declarations
Moss Genomics Inc. is a company focused on developing genomic solutions. It is listed on the XTSE market.